Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001771961-25-000014

Chief Accounting Officer sold 8,832 shares at an average $22.13 ($195,434)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Azoy Alexander · Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-16 Sale : show line 1 in the form 10b5-1 −2,376 $21.88 $51,997 24,987 D
2025-12-17 Sale : show line 2 in the form 10b5-1 −2,113 $22.16 $46,823 22,874 D
2025-12-18 Sale : show line 3 in the form 10b5-1 −4,343 $22.25 $96,614 18,531 D
Open-market sales · 8,832 sh · avg $22.13 · $195,434
Loading xslF345X05/wk-form4_1766097326.xml…